Skip to main content
. Author manuscript; available in PMC: 2014 Jun 2.
Published in final edited form as: Int J Infect Dis. 2011 Aug 19;15(11):e781–e786. doi: 10.1016/j.ijid.2011.07.002

Table 3.

Seroprevalence to influenza A/H1N1/2009 virus by gender and age grouped into decades

Characteristic Sample proportion, n (%) Age, mean ± SD Seropositive subjects Seropositivity prevalence, % (95% CI)a
Genderb
 Male 870 (39%) 28.4 (19.8) 364 41.8% (38.6–45.1)
 Female 1352 (61%) 35.2 (22.0) 495 36.6% (34.1–39.2)
Age grouped into decadesc
 6–10 229 (11%) 8.2 (1.5) 117 51.1% (44.7–57.5)
 11–20 623 (29%) 15.8 (2.8) 305 49.0% (45.0–52.9)
 21–30 321 (15%) 24.6 (3.0) 119 37.1% (32.0–42.5)
 31–40 311 (14%) 35.7 (2.9) 84 27.0% (22.4–32.2)
 41–50 313 (14%) 45.3 (2.9) 91 29.1% (24.3–34.3)
 51–60 143 (7%) 54.8 (2.9) 36 25.2% (18.8–32.9)
 61–70 45 (2%) 64.5 (2.7) 16 35.6% (23.2–50.2)
 71–80 61 (3%) 76.2 (2.8) 25 41.0% (29.5–53.5)
 81–90 80 (4%) 85.5 (2.5) 30 37.5% (27.7–48.5)
 91+ 34 (2%) 94.5 (3.4) 13 38.2% (23.9–55.0)

SD, standard deviation; CI, confidence interval.

a

Seropositivity prevalence data represent percentage and 95% CI of individuals with positive antibodies in that group.

b

Gender: p-value = 0.259.

c

Age cohort: p-value < 0.000; 62 missing values for decade of birth.

p-Values were obtained from a logistic model adjusted for gender and age.